SCHEMBL2779965

SCHEMBL2779965

O=C(O)c1cccnc1Oc1ccc(Br)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 2/20 0.45
CCR2 P41597 1/20 0.45
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 2/20 0.43
GPBAR1 Q8TDU6 3/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SORT1 Q99523 1/20 0.43
RAB9A P51151 4/20 0.42
MAPT P10636 3/20 0.42
NPC1 O15118 3/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
HPGD P15428 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2779685 0.88 MRGPRX4 (0.47) ROCK2SMN1; SMN2LMNACCR2ALDH1A1
SCHEMBL2336930 0.86 LMNA (0.47) SMN1; SMN2LMNACCR2ALDH1A1TDP1
SCHEMBL2336929 0.86 MRGPRX4 (0.54) SMN1; SMN2LMNACCR2ALDH1A1TDP1
SCHEMBL2783223 0.84 CCR2 (0.47) ROCK2SMN1; SMN2LMNACCR2KMT2A
SCHEMBL2782132 0.83 MAPK8 (0.53) ROCK2LMNAALDH1A1TDP1KDM4E
SCHEMBL2332795 0.82 TP53 (0.52) SMN1; SMN2LMNACCR2ALDH1A1TDP1
SCHEMBL2779673 0.82 RAB9A (0.48) SMN1; SMN2LMNACCR2ALDH1A1TDP1
SCHEMBL2781998 0.81 MRGPRX4 (0.56) TDP1MEN1KMT2A
SCHEMBL7431657 0.80 CCR2 (0.50) SMN1; SMN2LMNACCR2ALDH1A1TDP1
SCHEMBL2335696 0.80 GPBAR1 (0.60) SMN1; SMN2LMNACCR2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010091104-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS EXELIXIS, INC. (US) 2010-08-12 WO disclosed